Vinn
wanted to get your take on the clinical trial results for the cardiac stem cells that seems to be overshadowing mesoblast's trial results.
based on the impressive results, could this could cardiac stem cell technology be a serious competitor to Revascor?
as for the mesoblast trial results,were you underwhlemed by them or do you believe overall they were a success?
MT79
Vinnwanted to get your take on the clinical trial results for...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |